A trial testing IV NEPA to prevent nausea and vomiting in kids getting strong chemo
Part of Cancer clinical trials.
This trial tests a medicine called IV NEPA (fosnetupitant/palonosetron) to prevent nausea and vomiting in children who are receiving strong chemotherapy. Patients will receive at least one cycle of chemotherapy that is highly likely to cause these side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child between 0 months and 18 years old.
- You are scheduled to receive at least one cycle of strong chemotherapy (highly emetogenic) on a single day or over multiple days.
- You have a life expectancy of at least 3 months.
- If you are 10 years or older, you must be able to do daily activities with little help.
- Certain other health conditions may be okay if the study doctor says it is safe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection, HSK21542, to see if it can prevent nausea and vomiting caused by strong chemotherapy drugs. It may help people who have never had chemo before.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests whether the anti-nausea combination NEPA (netupitant and palonosetron) can prevent nausea and vomiting caused by the targeted therapy T-DXd in people with advanced HER2-positive or HER2-low breast cancer. It may help you if you are about to start T-DXd for the first time and want to manage treatment side effects.
This trial compares two forms of ondansetron (a nausea medicine) — a dissolving film you put in the mouth versus a needle injection — to see which works better in preventing nausea and vomiting caused by chemotherapy in children with solid tumors.
This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.
This trial tests if Akynzeo (a nausea medicine) helps prevent vomiting during chemotherapy for endometrial cancer. It is for people starting chemo for the first time.
Hear when a new Nausea and Vomiting Chemotherapy-Induced trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.